Low-Dose Lenalidomide after Non-Myeloablative Allogeneic Hematopoietic Cell Transplant with Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma
2018 ◽
Vol 24
(3)
◽
pp. S335
2009 ◽
Vol 15
(3)
◽
pp. 370-376
◽
2019 ◽
Vol 67
◽
pp. 194-201
◽
2015 ◽
Vol 56
(8)
◽
pp. 2392-2397
◽
2020 ◽
Vol 26
(3)
◽
pp. S298-S299